CIK 0001048477 · Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680397820
- Phone
- 4155066700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-20 | Dere Willard H Director | Grant or award | +6,650 | 38,950 | ||
| 2025-05-20 | Countouriotis Athena Director | Grant or award | +6,650 | 13,550 | ||
| 2025-05-20 | Bodem Barbara W. Director | Grant or award | +6,650 | 13,555 | ||
| 2025-05-20 | ANDERSON ELIZABETH M Director | Grant or award | +6,650 | 34,450 | ||
| 2025-05-20 | Burkhart Erin GVP, Chief Accounting Officer | Sale 10b5-1 | −1,786 | $59.31 | $106K | 14,173 |
| 2025-05-19 | Burkhart Erin GVP, Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −996 | $59.27 | $59K | 15,959 |
| 2025-05-02 | Hubbard Cristin EVP, Chief Commercial Officer | Sale 10b5-1 | −273 | $64.92 | $18K | 32,700 |
| 2025-04-30 | Hardy Alexander Chief Executive Officer | Grant or award | +375 | $54.14 | $20K | 175,958 |
| 2025-04-30 | Hubbard Cristin EVP, Chief Commercial Officer | Grant or award 10b5-1 | +273 | $54.14 | $15K | 32,973 |
| 2025-03-19 | Burkhart Erin GVP, Chief Accounting Officer | Sale 10b5-1 | −1,295 | $71.52 | $93K | 16,955 |
| 2025-03-17 | Burkhart Erin GVP, Chief Accounting Officer | Grant or award | +5,970 | 18,252 | ||
| 2025-03-17 | Burkhart Erin GVP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +9,230 | 9,230 | ||
| 2025-03-17 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +12,940 | 82,915 | ||
| 2025-03-17 | Davis George Eric EVP, Chief Legal Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +30,020 | 30,020 | ||
| 2025-03-17 | Hubbard Cristin EVP, Chief Commercial Officer | Grant or award | +13,310 | 32,700 | ||
| 2025-03-17 | Hubbard Cristin EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +30,880 | 30,880 | ||
| 2025-03-17 | Friberg Gregory R EVP, Chief R&D Officer | Grant or award | +17,750 | 46,810 | ||
| 2025-03-17 | Friberg Gregory R EVP, Chief R&D Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +41,170 | 41,170 | ||
| 2025-03-17 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +13,310 | 80,838 | ||
| 2025-03-17 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +30,880 | 30,880 |
Page 4 of 10 · 187 trades